CRL · News · 20260805N
Net Income and Profitability
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 45 · Surprise 50
CRL swung to a Q2 2026 GAAP net loss of $1.5 million, or $0.03 per share, primarily because of divestiture losses. Adjusted Q2 earnings were $3.02 per share, exceeding the $2.72 consensus estimate but declining from $3.12 a year earlier. Management raised its full-year 2026 adjusted EPS outlook to $11.15–$11.45. Portfolio refinements, cost reductions, and improved Manufacturing performance supported expected margin expansion.